XML 19 R9.htm IDEA: XBRL DOCUMENT
v3.20.2

Divestitures | 9 Months Ended
--- | ---
Jun. 30, 2020
Divestitures [Abstract] |
Divestitures | NOTE B – DIVESTITURES Composites and Marl facility On August 30, 2019, Ashland completed the sale of its Composites business (excluding the Maleic business) and butanediol manufacturing facility in Marl, Germany to INEOS Enterprises for $1.015 billion. The operating results and cash flows related to Composites and the Marl facility, including the Maleic business, have been reflected as discontinued operations in the Statements of Consolidated Comprehensive Income (Loss) and Statements of Condensed Consolidated Cash Flows. See Note C of the Notes to Condensed Consolidated Financial Statements for the results of operations for Composites and the Marl facility, including the Maleic business, for all periods presented. Certain indirect corporate costs included within the selling, general and administrative expense caption of the Statements of Consolidated Comprehensive Income (Loss) that were previously allocated to the Composites segment and Marl facility do not qualify for classification within discontinued operations and are now reported as selling, general and administrative expense within continuing operations on a consolidated basis and within the Unallocated and other segment. These costs were zero for the three and nine months ended June 30, 2020, and $10 million and $33 million during the three and nine months ended June 30, 2019, respectively. Subsequent to the completion of the sale, Ashland is providing certain transition services to INEOS for a fee. While the transition services are expected to vary in duration depending upon the type of service provided, Ashland expects to reduce certain costs as the transition services are completed. Ashland recognized transition service fee income of $3 million and $9 million for the three and nine months periods ended June 30, 2020, respectively. Held for sale classification The assets and liabilities of the Maleic business, along with certain other corporate property, have been reflected as assets and liabilities held for sale. As a result depreciation and amortization are not being recorded within the Statements of Consolidated Comprehensive Income (Loss) and the Condensed Consolidated Balance Sheets. These assets and liabilities are comprised of the following components:
|  | June 30 |  |  | September 30 |
(In millions) |  | 2020 |  |  | 2019 |
Accounts receivable, net |  | $ | 6 |  |  | $ | 5 |
Inventories |  |  | 2 |  |  |  | 3 |
Net property, plant and equipment |  |  | 34 |  |  |  | 34 |
Goodwill |  |  | 14 |  |  |  | 14 |
Other assets |  |  | 5 |  |  |  | 3 |
Current assets held for sale |  | $ | 61 |  |  | $ | 59 |
Trade and other payables |  | $ | 4 |  |  | $ | 6 |
Accrued expenses and other liabilities |  |  | 1 |  |  |  | 1 |
Current liabilities held for sale |  | $ | 5 |  |  | $ | 7 |

X
- Definition Divestitures. + References No definition available. + Details
Name: | ash_DivestituresAbstract
Namespace Prefix: | ash_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of completed or expected disposal(s) group, the gain or loss recognized in the income statement and the income statement caption that includes that gain or loss, amounts of revenues and pretax profit or loss reported in earnings, the segment in which the disposal group was reported, and the classification and carrying value of the assets and liabilities comprising the disposal group. + References No definition available. + Details
Name: | ash_DivestituresTextBlock
Namespace Prefix: | ash_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration